EXAS logo

ARKK Holdings of EXAS

Exact Sciences Corp.

Exact Sciences Corporation is a molecular diagnostics company specializing in the detection and prevention of certain types of cancer. The company makes money by developing and selling non-invasive screening tests, such as Cologuard, for early cancer detection, primarily generating revenue through product sales and service agreements with healthcare providers.

#108 in All Funds#34 in ARKG

Trades of EXAS in ARKK

The ten most recent trades of Exact Sciences Corp. in the ARKK ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Jul 01, 2024Sell$20,1581.33%0.00%
Jun 27, 2024Sell$623,42639.14%0.01%
Jun 10, 2024Sell$2,118,0617.76%0.03%
Jun 06, 2024Sell$2,464,1147.93%0.04%
Jun 04, 2024Sell$3,837,76631.33%0.06%
Jun 03, 2024Sell$1,500,14810.55%0.02%
May 10, 2024Sell$16,301,90148.59%0.25%
May 09, 2024Sell$39,004,62853.70%0.61%
May 01, 2024Sell$6,441,4816.92%0.10%
Apr 02, 2024Sell$14,301,27710.25%0.19%